| Announce Date | 08/05/2025 |
| EPS Normalized Actual | $0.13 (Miss by $-0.44) |
| EPS GAAP Actual | $0.13 (Miss by $-0.44) |
| Revenue Actual | $0.798017B |
| Revenue Surprise | Beat by $798.017M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 5.73 | 6.84 | 5.23905 | 6.04264 | 2 |
| Dec 2026 | 7.89258 | 4.97 | 6.87517 | 8.91 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.13 | -0.13 | 0.798017B | -0.32% | 798.02M |
| FQ2 2025 (Jun 2025) | -0.73 | -0.73 | 0B | -INF% | 0M |
| FQ1 2025 (Mar 2025) | 0.73 | 0.73 | 0B | -INF% | 0M |
| FQ4 2024 (Dec 2024) | 0.5545 | 0.5545 | 0.927341B | 30.66% | 927.34M |
| FQ3 2024 (Sep 2024) | 0 | 0 | 0.800549B | 12.88% | 800.55M |
| FQ2 2024 (Jun 2024) | 0 | 0 | 0.692844B | 99.91% | 692.84M |
| FQ1 2024 (Mar 2024) | 0 | 0 | 0.637084B | 3.93% | 637.08M |
| FQ4 2023 (Dec 2023) | 1.06 | 1.06 | 0.642979B | 100% | 642.98M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 0.47146 | -- | 0.45723 | 0.48106 | 2 |
| FQ3 2028 (Sep 2028) | 0.52029 | -- | 0.50458 | 0.53088 | 2 |
| FQ2 2028 (Jun 2028) | 0.5287 | -- | 0.51274 | 0.53947 | 2 |
| FQ1 2028 (Mar 2028) | 0.44913 | -- | 0.43557 | 0.45828 | 2 |
| FQ4 2027 (Dec 2027) | 0.58282 | -- | 0.5624 | 0.59637 | 1 |
| FQ3 2027 (Sep 2027) | 0.5881 | -- | 0.5675 | 0.60177 | 1 |
| FQ2 2027 (Jun 2027) | 0.55193 | -- | 0.53259 | 0.56476 | 1 |
| FQ1 2027 (Mar 2027) | 0.52402 | -- | 0.50566 | 0.5362 | 1 |
| FQ4 2026 (Oct 2026) | 1.80895 | -- | 1.7651 | 1.87188 | 0 |
| FQ3 2026 (Sep 2026) | 1.93276 | 106.73 | 1.82512 | 2.051 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 0.81B | -- | 0.79B | 0.82B | 1 |
| FQ3 2028 (Sep 2028) | 0.8B | -- | 0.78B | 0.82B | 1 |
| FQ2 2028 (Jun 2028) | 0.81B | -- | 0.79B | 0.82B | 1 |
| FQ1 2028 (Mar 2028) | 0.77B | -- | 0.76B | 0.79B | 1 |
| FQ4 2027 (Dec 2027) | 0.86B | -- | 0.83B | 0.87B | 2 |
| FQ3 2027 (Sep 2027) | 0.85B | -- | 0.83B | 0.87B | 2 |
| FQ2 2027 (Jun 2027) | 0.84B | -- | 0.82B | 0.86B | 2 |
| FQ1 2027 (Mar 2027) | 0.83B | -- | 0.81B | 0.84B | 2 |
| FQ4 2026 (Oct 2026) | 1.18B | -- | 1.16B | 1.21B | 2 |
| FQ3 2026 (Sep 2026) | 2.41B | 66.9 | 2.31B | 2.52B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
2
EPS # of in-lines
3
Revenue # of Beats
6
Revenue # of Misses
0
Revenue # of in-lines
2
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.13 | -0.13 | 100% | |
| FQ2 2025 (Jun 2025) | -0.73 | -0.73 | 100% | |
| FQ1 2025 (Mar 2025) | 0.73 | 0.73 | 100% | |
| FQ4 2024 (Dec 2024) | 0.5545 | 0.5545 | 100% | |
| FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
| FQ2 2024 (Jun 2024) | 0 | 0 | NAN% | |
| FQ1 2024 (Mar 2024) | 0 | 0 | NAN% | |
| FQ4 2023 (Dec 2023) | 1.06 | 1.06 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0.8B | $798.02M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $0B | $0M | NAN% |
| FQ1 2025 (Mar 2025) | $0B | $0B | $0M | NAN% |
| FQ4 2024 (Dec 2024) | $0B | $0.93B | $927.34M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.8B | $800.55M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.69B | $692.84M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.64B | $637.08M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.64B | $642.98M | 100% |